Grafa makes finance simple and entertaining. It allows anyone, anywhere in the world to quickly research, get tips and understand investment opportunities.
Treatment Efficacy
Grafa topics
Grafa
03/12/2024
Roivant Halts namilumab development after trial setback
Grafa
03/10/2024
Abivax's Obefazimod shows promise in ulcerative colitis maintenance study
Grafa
26/09/2024
FDA approves AstraZeneca's Tagrisso for stage III non-small cell lung cancer
Grafa
18/09/2024
4D Molecular Therapeutics unveils promising data in wet AMD trial
Grafa
11/09/2024
GSK's HPV vaccine trial falls short of primary target
Grafa
09/09/2024
Summit Therapeutics surges after lung cancer trial success
Grafa
03/09/2024
PRAXIS (NASDAQ:PRAX) announces promising relutrigine study results
Grafa
25/07/2024
Amplia Therapeutics (ASX:ATX) reports results in Phase 2a ACCENT trial
Grafa
12/07/2024
Immutep's (ASX:IMM) combination therapy shows efficacy in head and neck cancer trial
Grafa
17/06/2024
Nurix Therapeutics (NASDAQ:NRIX) shines with NX-5948 trial data
Hub
News
Watchlist
Hot
Markets